FISOF yields 852.88% · JNJ yields 2.13%● Live data
📍 FISOF pulled ahead of the other in Year 1
Combined, FISOF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FISOF + JNJ for your $10,000?
Fission 3.0 Corp. engages in the acquisition, exploration, and development of uranium resource properties. The company holds 100% interests in the Clearwater West property that comprises 3 contiguous claims covering 11,786 hectares located in Saskatchewan, Canada; the Patterson Lake North property that consists of 38 claims covering 39,946 hectares situated in Saskatchewan, Canada; the Wales Lake property that comprises 31 claims covering an area of 40,986 hectares located in southwest Athabasca basin; and the Key Lake area portfolio consisting of the Bird Lake, Grey Island, Hobo Lake, Lazy Edward Bay, and Seahorse Lake properties, which comprise 81 claims and 57,131 hectares located in Saskatchewan, Canada. It also has 100% interests in the Beaverlodge/uranium city area portfolio that consists of 50 claims and 41,537 hectares located in Saskatchewan, Canada; and the northeast Athabasca basin area, which comprise 36 claims covering an area of 21,059 hectares situated in Saskatchewan, Canada. The company was incorporated in 2013 and is headquartered in Kelowna, Canada.
Full FISOF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.